Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Active Pharmaceutical Ingredient Sales Market Report 2020

  • QYR629895
  • 124 Pages
  • July 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Active Pharmaceutical Ingredient in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering

Teva

Novartis

Pfizer

Johnson & Johnson

Mylan

North China Pharmaceutical Group

Dr. Reddy’s Laboratories

Roche

Aurobindo pharma

Sun Pharmaceutical Industries

Boehringer Ingelheim GmbH

Bayer

BASF

DSM

Zhejiang Medicine

Biocon

Johnson Matthey

Hisun Pharmacy

Cambrex

Shandong Xinhua Pharmaceutical

Lonza group

Huahai Pharmaceutical

Haerbin Pharmaceutical Group

Cipla

Tian Yao

Lupin

North East Pharmaceutical

Albemarle

Shandong Lukang Pharmaceutical

Jiangsu?Hengrui Medicine

Table of Contents

United States Active Pharmaceutical Ingredient Sales Market Report 2020

1 Active Pharmaceutical Ingredient Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredient

1.2 Classification of Active Pharmaceutical Ingredient

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Applications of Active Pharmaceutical Ingredient

1.4 USA Market Size (Value and Volume) of Active Pharmaceutical Ingredient (2011-2020)

1.4.1 USA Active Pharmaceutical Ingredient Sales, Revenue and Price (2011-2020)

1.4.2 USA Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)

1.4.3 USA Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)

2 USA Active Pharmaceutical Ingredient Competition by Manufacturers

2.1 USA Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Active Pharmaceutical Ingredient Revenue and Share by Manufactures (2015-2016)

3 USA Active Pharmaceutical Ingredient (Volume and Value) by Type

3.1 USA Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2020)

3.2 USA Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011 and 2020)

4 USA Active Pharmaceutical Ingredient (Volume) by Application

5 USA Active Pharmaceutical Ingredient Manufacturers Analysis

5.1 Teva

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Active Pharmaceutical Ingredient Product Type and Technology

5.1.2.1 Type 1

5.1.2.2 Type 2

5.1.3 Active Pharmaceutical Ingredient Sales, Revenue, Price of Teva (2015 and 2016)

5.2 Novartis

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Chemical & Material Product Type and Technology

5.2.2.1 Type 1

5.2.2.2 Type 2

5.2.3 Chemical & Material Sales, Revenue, Price of Novartis (2015 and 2016)

5.3 Pfizer

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Pfizer Product Type and Technology

5.3.2.1 Type 1

5.3.2.2 Type 2

5.3.3 Pfizer Sales, Revenue, Price of Pfizer (2015 and 2016)

5.4 Johnson & Johnson

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Aurobindo pharma Product Type and Technology

5.4.2.1 Type 1

5.4.2.2 Type 2

5.4.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.5 Mylan

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Mylan Product Type and Technology

5.5.2.1 Type 1

5.5.2.2 Type 2

5.5.3 Mylan Sales, Revenue, Price of Mylan (2015 and 2016)

5.6 North China Pharmaceutical Group

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 North China Pharmaceutical Group Product Type and Technology

5.6.2.1 Type 1

5.6.2.2 Type 2

5.6.3 North China Pharmaceutical Group Sales, Revenue, Price of North China Pharmaceutical Group (2015 and 2016)

5.7 Dr. Reddy’s Laboratories

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Dr. Reddy’s Laboratories Product Type and Technology

5.7.2.1 Type 1

5.7.2.2 Type 2

5.7.3 Dr. Reddy’s Laboratories Sales, Revenue, Price of Dr. Reddy’s Laboratories (2015 and 2016)

5.8 Roche

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Roche Product Type and Technology

5.8.2.1 Type 1

5.8.2.2 Type 2

5.8.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)

5.9 Aurobindo pharma

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Aurobindo pharma Product Type and Technology

5.9.2.1 Type 1

5.9.2.2 Type 2

5.9.3 Aurobindo pharma Sales, Revenue, Price of Aurobindo pharma (2015 and 2016)

5.10 Sun Pharmaceutical Industries

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Sun Pharmaceutical Industries Product Type and Technology

5.10.2.1 Type 1

5.10.2.2 Type 2

5.10.3 Sun Pharmaceutical Industries Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)

5.11 Boehringer Ingelheim GmbH

5.12 Bayer

5.13 BASF

5.14 DSM

5.15 Zhejiang Medicine

5.16 Biocon

5.17 Johnson Matthey

5.18 Hisun Pharmacy

5.19 Cambrex

5.20 Shandong Xinhua Pharmaceutical

5.21 Lonza group

5.22 Huahai Pharmaceutical

5.23 Haerbin Pharmaceutical Group

5.24 Cipla

5.25 Tian Yao

5.26 Lupin

5.27 North East Pharmaceutical

5.28 Albemarle

5.29 Shandong Lukang Pharmaceutical

5.30 Jiangsu?Hengrui Medicine

6 Active Pharmaceutical Ingredient Technology and Development Trend

6.1 Active Pharmaceutical Ingredient Technology Analysis

6.2 Active Pharmaceutical Ingredient Technology Development Trend

7 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Active Pharmaceutical Ingredient

Table Classification of Active Pharmaceutical Ingredient

Figure USA Sales Market Share of Active Pharmaceutical Ingredient by Types in 2015

Table Applications of Active Pharmaceutical Ingredient

Figure USA Sales Market Share of Active Pharmaceutical Ingredient by Applications in 2016

Table USA Active Pharmaceutical Ingredient Sales, Revenue and Price (2011-2020)

Figure USA Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2020)

Figure USA Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2020)

Table USA AAA Sales of Key Manufacturers (2015 and 2016)

Table USA AAA Sales Share by Manufacturers (2015 and 2016)

Figure 2015 AAA Sales Share by Manufacturers

Figure 2016 AAA Sales Share by Manufacturers

Table USA AAA Revenue by Manufacturers (2015 and 2016)

Table USA AAA Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA AAA Revenue Share by Manufacturers

Table 2016 USA AAA Revenue Share by Manufacturers

Table USA AAA Sales and Market Share by Type (2011-2020)

Table USA AAA Sales Share by Type (2011-2020)

Figure Sales Market Share of AAA by Type (2011-2020)

Figure USA AAA Sales Growth Rate by Type (2011-2020)

Table USA AAA Revenue and Market Share by Type (2011-2020)

Table USA AAA Revenue Share by Type (2011-2020)

Figure Revenue Market Share of AAA by Type (2011-2020)

Figure USA AAA Revenue Growth Rate by Type (2011-2020)

Table USA AAA Sales and Market Share by Application (2011-2020)

Table USA AAA Sales Share by Application (2011-2020)

Figure Sales Market Share of AAA by Application (2011-2020)

Figure USA AAA Sales Growth Rate by Application (2011-2020)

Table Teva Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Teva (2015 and 2016)

Table Novartis Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table Mylan Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Mylan (2015 and 2016)

Table North China Pharmaceutical Group Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of North China Pharmaceutical Group (2015 and 2016)

Table Dr. Reddy’s Laboratories Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Dr. Reddy’s Laboratories (2015 and 2016)

Table Roche Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Roche (2015 and 2016)

Table Aurobindo pharma Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Aurobindo pharma (2015 and 2016)

Table Sun Pharmaceutical Industries Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Sun Pharmaceutical Industries (2015 and 2016)

Table Boehringer Ingelheim GmbH Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Boehringer Ingelheim GmbH (2015 and 2016)

Table Bayer Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Bayer (2015 and 2016)

Table BASF Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of BASF (2015 and 2016)

Table DSM Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of DSM (2015 and 2016)

Table Zhejiang Medicine Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Zhejiang Medicine (2015 and 2016)

Table Biocon Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Biocon (2015 and 2016)

Table Johnson Matthey Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Johnson Matthey (2015 and 2016)

Table Hisun Pharmacy Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Hisun Pharmacy (2015 and 2016)

Table Cambrex Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Cambrex (2015 and 2016)

Table Shandong Xinhua Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Shandong Xinhua Pharmaceutical (2015 and 2016)

Table Lonza group Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Lonza group (2015 and 2016)

Table Huahai Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Huahai Pharmaceutical (2015 and 2016)

Table Haerbin Pharmaceutical Group Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Haerbin Pharmaceutical Group (2015 and 2016)

Table Cipla Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Cipla (2015 and 2016)

Table Tian Yao Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Tian Yao (2015 and 2016)

Table Lupin Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Lupin (2015 and 2016)

Table North East Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of North East Pharmaceutical (2015 and 2016)

Table Albemarle Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Albemarle (2015 and 2016)

Table Shandong Lukang Pharmaceutical Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Shandong Lukang Pharmaceutical (2015 and 2016)

Table Jiangsu?Hengrui Medicine Basic Information List

Table Active Pharmaceutical Ingredient Sales, Revenue, Price of Jiangsu?Hengrui Medicine (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390